SCHEMBL2899550

SCHEMBL2899550

N#Cc1ccc(-c2ccc(CCl)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LOXL2 Q9Y4K0 2/20 0.52
CYP2A6 P11509 1/20 0.52
MMP3 P08254 1/20 0.52
CYP19A1 P11511 4/20 0.52
TSHR P16473 1/20 0.52
HSD17B10 Q99714 1/20 0.52
KIF11 P52732 2/20 0.47
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HRH3 Q9Y5N1 2/20 0.44
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA9 Q16790 1/20 0.44
MMP12 P39900 1/20 0.44
MMP13 P45452 1/20 0.44
ALDH1A1 P00352 1/20 0.44
HPGD P15428 1/20 0.44
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL200142 0.93 LOXL2 (0.58) LOXL2CYP2A6CYP19A1TSHRCA12
SCHEMBL9161636 0.86 LOXL2 (0.54) LOXL2CYP2A6CYP19A1HRH3CA12
SCHEMBL1641362 0.83 HRH3 (0.61) HRH3
Water SCHEMBL11480029 0.83 HRH3 (0.45) TSHRHRH3CA1CA2MAOB
SCHEMBL14155434 0.81 LOXL2 (0.58) LOXL2CYP2A6MMP3CYP19A1TSHR
SCHEMBL16848648 0.81 LOXL2 (0.58) LOXL2CYP2A6MMP3CYP19A1TSHR
SCHEMBL2999573 0.81 PARP15 (0.49) LOXL2CYP2A6CYP19A1HRH3ALDH1A1
SCHEMBL9456876 0.80 HRH3 (0.47) TSHRHRH3CA1CA2MAOB
SCHEMBL187751 0.80 HRH3 (0.47) TSHRHRH3CA1CA2MAOB
SCHEMBL396846 0.80 MMP3 (0.74) LOXL2CYP2A6MMP3TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7700653-B2 Halogen-substituted aminodicarboxylic acid derivatives BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2010-04-20 US disclosed
US-7067694-B2 Halogen-substituted amino dicarboxylic acid derivatives as medicaments for treating cardiovascular diseases BAYER AKTIENGESELLSCHAFT (DE) 2006-06-27 US disclosed
US-20060111444-A1 Novel halogen-substituted aminodicarboxylic acid derivatives BAYER AKTIENGESELLSCHAFT (DE) 2006-05-25 US disclosed
EP-0574808-A1 Amidine-biphenyl derivatives, process for their production & medical preparation containing them Dr. Karl Thomae GmbH (DE) 1993-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111444-A1 Novel halogen-substituted aminodicarboxylic acid derivatives FABP3, PPARD, FABP1 LOXL2 334/4885CYP2A6 65/4885MMP3 1906/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.